Electrical Stimulation for Glaucoma

Recruiting in Palo Alto (17 mi)

Overseen byJeffrey L Goldberg, MD PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1 & 2

Waitlist Available

Sponsor: Stanford University

Trial Summary

What is the purpose of this trial?

The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.

Research Team

Jeffrey L Goldberg, MD PhD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for individuals with open-angle glaucoma, a common eye condition that can lead to vision loss. Specific eligibility criteria are not provided, but typically participants would need to meet certain health standards and not have conditions that could interfere with the study.

Inclusion Criteria

I am 18 years old or older.

Participant's eye pressure must be clinically stable, with IOP < 18.

If a participant has two eyes meeting study criteria, the worse eye will be deemed includable.

See 3 more

Exclusion Criteria

Participant has a history of ocular herpes zoster.

Participant is currently participating in or has recently participated in another clinical trial.

Participant is pregnant or lactating.

See 7 more

Treatment Details

Interventions

Eyetronic rtACS (Electrical Stimulation)

Trial OverviewThe trial is testing the effectiveness of a treatment called transorbital alternating current stimulation (rtACS) using a device named EYETRONIC. It's compared against a sham rtACS, which is like a placebo where no actual stimulation is given.

Participant Groups

2Treatment groups

Experimental Treatment

Placebo Group

Group I: rtACS treatmentExperimental Treatment1 Intervention

Participants will receive 10 days of rtACS treatment in office.

Group II: ShamPlacebo Group1 Intervention

Participants will be wearing device but no stimulation will occur for 10 treatments in office.